Presenter: Gonzalo J. Rubio, Executive Medical Director, Oncology

Pending Challenges in early-phase Clinical Studies of Immunotherapy, Gonzalo J. Rubio, Executive Medical Director, Oncology.

  • Paradigms in endpoint selection
  • Risks of continuing using an extrapolated modeling
  • Seamless study designs: pros and cons
  • Redundancy and inefficiency
  • Combination studies
  • Future directions

Dr Gonzalo J. Rubio has more than 25 years expertise in Oncology Clinical Drug Development, from early phase studies up to regulatory registration, pharmacovigilance and post-marketing research, both as Investigator and Medical Monitor

Watch The Webinar

Back to Knowledge Hub